KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Intangibles (2016 - 2026)

Eli Lilly filings provide 16 years of Intangibles readings, the most recent being $7.4 billion for Q1 2026.

  • On a quarterly basis, Intangibles rose 22.65% to $7.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.4 billion, a 22.65% increase, with the full-year FY2025 number at $6.5 billion, up 5.76% from a year prior.
  • Intangibles hit $7.4 billion in Q1 2026 for Eli Lilly, up from $6.5 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $7.5 billion in Q2 2022 to a low of $5.9 billion in Q2 2025.
  • Median Intangibles over the past 5 years was $6.8 billion (2023), compared with a mean of $6.8 billion.
  • Biggest five-year swings in Intangibles: decreased 11.09% in 2025 and later grew 22.65% in 2026.
  • Eli Lilly's Intangibles stood at $7.2 billion in 2022, then fell by 4.16% to $6.9 billion in 2023, then dropped by 10.72% to $6.2 billion in 2024, then grew by 5.76% to $6.5 billion in 2025, then rose by 13.08% to $7.4 billion in 2026.
  • The last three reported values for Intangibles were $7.4 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.4 billion (Q3 2025) per Business Quant data.